Torrey Growth & Income Advisors
Source: SEC Form 13F · as of Mar 2026Torrey Growth & Income Advisors holds 13 biotech & pharma companies tracked by BioSniper, totaling $23.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$23.9M
| Company | Shares | Value |
|---|---|---|
| PFEPFIZER INC | 332,667 | $9.3M |
| LLYELI LILLY & Co | 5,247 | $4.8M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 4,710 | $2.1M |
| NVONovo Nordisk A/S | 55,783 | $2.0M |
| VCELVericel Corp | 44,683 | $1.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,656 | $972K |
| ABBVAbbVie Inc. | 4,253 | $921K |
| NTLAIntellia Therapeutics, Inc. | 70,547 | $886K |
| MRNAModerna, Inc. | 9,350 | $461K |
| IBRXImmunityBio, Inc. | 55,450 | $405K |
| CADLCandel Therapeutics, Inc. | 67,148 | $318K |
| ELVElevance Health Inc. | 826 | $239K |
| SPROSpero Therapeutics, Inc. | 17,025 | $38K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.